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ABSTRACT 
X-ray computed tomography (CT) is a powerful and widely used medical non-invasive 
technique that requires intravenously administration of contrast agents to enhance the 
sensitivity and visualization of soft tissues. In this work, we have developed a novel CT 
contrast agent based on ternary Ag-Au-Se chalcogenide nanoparticles. A facile and gentle 
ligand exchange by using a 3 kDa PEGylated ligand with a dithiol dihydrolipoic as an 
anchor resulted in highly water-soluble and monodisperse nanoparticles. Moreover, the 
injected PEGylated ternary NPs presented excellent characteristics as a CT contrast agent 
with high bioavailability, low cytotoxicity and long blood circulation times with slow 
uptake by the mononuclear phagocyte system, thus being ideal for in vivo imaging. 
 
INTRODUCTION 
Computed Tomography (CT) is one of the most commonly used medical imaging 
diagnostic techniques. This powerful non-invasive technique provides high spatial (3-D) 
and temporal resolution images, based on the attenuation of the X-ray intensity. Thus, CT 
is extensively used in certain tissues such as the cardiovascular system, the gastro-
intestinal tract and the brain, especially for studies that require high speed in data 
acquisition, such as the visualization of cardiac motion. However, X-ray CT presents 
some intrinsic drawbacks such as low sensitivity, ionizing radiation, and limited contrast 
in soft tissues. Both sensitivity and contrast can be improved by using contrast agents, 
such as the iodine derivatives currently available for clinical applications. However, these 
contrast agents show important drawbacks, namely, short circulation times with rapid 
renal clearance, side toxicity effects due to the necessity of high doses, and inefficient X-
ray attenuation with the consequent use of high energy X-rays. To overcome these 
limitations engineered nanoparticles based on elements with higher atomic number than 
iodine (Z = 53), like lanthanides, tantalum, bismuth and gold have been synthesized as 
novel CT contrast agents. Among these engineered CT contrast agents, gold-based 
nanoparticles have received considerable attention due to the low toxicity, higher X-ray 
attenuation, the ease to control the size, shape and morphology of the NP in the synthesis 
and the efficacy on the functionalization with thiolated derivates. Furthermore, prolonged 
blood circulation times and better bioavailability can be achieved by controlling other 
factors such as the organic coating or the outermost surface charge of the nanoparticles. 
Recently, our research group has demonstrated that coating small NPs (~6 nm) with 3kDa 
PEG-OH molecules resulted in optimal stealth properties and increased blood circulation 
times, thus turning these NPs into potential contrast agents for molecular imaging or 
tumor targeting. 
Herein, we report the synthesis of water soluble ternary Ag-Au-Se nanocomposites. 
Interestingly, this noble metal-based ternary chalcogenide system has been tested 
previously as a potential thermoelectric energy conversion material. (ref. Dalmases, M. 
et al. Chem. Mater. 2016, 28, 7017-7028) However, their applications in the field of 
biomedicine have not been explored yet. In addition to the presence of gold in the 
nanoparticle composition, the selenium could provide important functions as a reducing 
cancer agent, and silver could be utilized as a potential biosensor or anti-microbial agent, 
among others, thus giving to this chalcogenide system a high potential for biomedical 
applications. In this report, we explored the application of these rare Ag-Au-Se ternary 
nanostructures as novel X-ray computed tomography contrast agents. To achieve this aim, 
the ternary nanocomposites were transfered in aqueous medium by a simple ligand 
exchange functionalization. The use of a ligand with a dihydrolipoic acid (DHLA) anchor 
combined with a 3 kDa poly ethylene glycol (PEG) chain provided highly water-soluble 
stable rare ternary nanoparticles that exhibited excellent in vitro and in vivo properties as 
X-rays CT contrast agents with long blood circulation times. 
RESULTS AND DISCUSSION 
Ligand exchange protocol for the Ag3AuSe2 nanoparticles. 
To render water-soluble rare Ag-Au-Se ternary nanoparticles, we designed a modular 
ligand DHLA-PEGn-OH that presents a dithiol terminal group to strongly anchor the 
nanoparticle surface and a PEGylated chain of 3 kDa to ensure the solubility in water, the 
stability on different media, like physiological solution and plasma, and minimize plasma 
proteins adsorption to avoid a rapid clearance by the mononuclear phagocytic system 
(MPS). The ligand exchange occurs by a previous ring opening reduction of the disulfide 
LA-PEGn-OH to the more active form, dithiol DHLA-PEGn-OH. Then, a vigorous 
shaking of a toluene (or chloroform) solution of monodisperse rare Ag-Au-Se ternary 
nanoparticles, the corresponding PEGylated dithiol DHLA-PEGn-OH and triethylamine 
as a strong base, brought an effective cap exchange of the stabilizing surfactants onto the 
ternary nanoparticles. The PEGylated ternary nanoparticles were automatically 
transferred to the aqueous phase without perturbing the colloidal properties of the hybrid 
nanocomposites as shown in Figure 1. This step is the more critical aspect to take into 
consideration since the functionalization process and in particular the transfer of the 
nanoparticles in aqueous solution could bring the formation of agglomerates or 
uncontrolled aggregation with the consequent loss or modification of their properties. 
TEM images showed that the PEGylated nanoparticles kept the same colloidal 
distribution that the hydrophobic nanoparticles. Although the TEM images showed 
similar diameter sizes and a great colloidal stability, the hydrodynamic diameter sizes 
were also measured through Dynamic Light Scattering (DLS) to obtain a more complete 
information on the behavior of the bulk hybrid nanoparticle solution. The hydrophilic 
nanoparticles presented HD diameters of 30.6 and 25.4 nm in PBS and plasma 
respectively, thus indicating the absence of aggregates. Furthermore, the negative values 
measured in the Z-potential allow the nanoparticles to reduce uncontrolled aggregation in 
plasma, as shown in Figure 2. The presence of the dithiol PEGylated at the nanoparticle 
surface was also confirmed by different physico-chemical techniques such as FTIR, 1H 
NMR and UV-Vis spectroscopies (Figure 3). The FTIR spectra before and after the 
functionalization are shown in Figure 3a. As can be observed, the spectrum of the 
hydrophilic hybrid nanoparticle showed the presence of the main peaks of the DHLA-
PEG-OH ligand: 1466 cm-1 (C-H bend vibration), 1359 cm-1 (C-H bend vibration), 1341 
cm-1 (C-H bend vibration), 1307 cm-1 (anti-symmetric stretch vibration), 1268 cm-1 (C-O 
stretch vibration), 1238 cm-1 (C-O stretch vibration), 1092 cm-1 (C-O-C stretch vibration) 
and 942 cm-1 (CH out-of-plane bending vibration). In the same manner, the NMR analysis 
of the hydrophilic PEGylated nanoparticles resulted in a 1H NMR spectrum practically 
identical to the DHLA-PEG-OH ligand (Figure 3b). UV-Vis analysis of the nanoparticles 
showed no significant changes before and after functionalization (Figure 3c). Ag3AuSe2 
has been theoretically identified as a semiconductor with a band gap energy of ca. 0.2 eV. 
(ref. C. M. Fang et al. Journal of Physics and Chemistry of Solids, 63 (2002) 457-464) 
Such a small band gap would in principle be responsible for absorption of very low energy 
photons at the near infrared region, above 1000 nm, although this has never been 
experimentally reported yet. In both spectra, before and after functionalization, a weak 
and wide absorption band (or group of bands) between 500 and 700 nm can be observed. 
These bands could be assigned either to the intrinsic band structure of the ternary 
Ag3AuSe2 material, or to the Surface Plasmon Resonance (SPR) absorption band of a 
small population of metallic Au nanoparticles  that might have been formed during the 
synthesis of the ternary Ag3AuSe2 nanostructures. In order to discern between the two 
hypotheses, powder X-ray diffraction measurements were performed to the sample before 
functionalization. The XRD spectrum does not show any band confirming the presence 
of metallic Au, but this could be due to both the low amount of Au nanoparticles and to 
their very small domain size. Thus, the origin of the 500-700 nm absorption band can not 
be unambiguously assigned to a Ag3AuSe2 intraband transition or simply to the presence 
of metallic Au impurities. After ligand exchange, the new absorption band below 450 nm 
can be assigned to the PEGylated ligand (Figure 3c, black). To quantify the amount of 
ligand attached to the hybrid ternary nanoparticle, a thermo-gravimetric analysis (TGA) 
was performed, resulting that the 80% of the weight corresponds to the organic ligand 
(Figure 3d). It is worth mentioning that before performing all these experiments, a 
thorough purification process was done by filtering the solution in a centrifuge device 
with a MWCO 30kDa under centrifugation (4500 rpm for 20 min) till the filtered solution 
remained clean and free of excess ligand. 
Cytotoxicity 
After an exhaustive physical chemical characterization, the following step was the 
evaluation of the cellular biocompatibility of the PEGylated rare Ag-Au-Se ternary 
nanoparticles. Since, the presence of silver cations in the nanoparticles could lead to 
severe toxicity problems, the cytotoxicity of the hybrid nanoparticles was evaluated using 
the C6 rat glioma cell line as a working model. The cultured cells were exposed to 
increasing concentration of the PEGylated rare Ag-Au-Se ternary nanoparticles from 0.5 
μg/mL to 500 μg/mL for 24 h (Figure 4a), giving as result 100% of cell viability even at 
the high concentration of 50 μg/mL, with a calculated LD50 of 296 μg/mL (Figure 4b). 
This means that the PEGylation onto the ternary nanoparticles protects the inorganic 
surface from the external medium avoiding possible leaching of cations from the 
inorganic nanoparticle. These results support the great potential of these rare Ag-Au-Se 
nanoparticles in biomedical applications, as reported below in the following section. 
In vivo studies 
After the in vitro characterization of the PEGylated rare ternary nanoparticles, we 
performed in vivo studies of biodistribution and the bioavailability of these metal NPs to 
evaluate their potential as Computed Tomography contrast agents. Thus, after the 
inoculation in the tail vein of 10 mg of NPs per kg of balb/c mouse, we followed and 
quantified by CT the in vivo accumulation of the injected nanoparticles in different organs 
at 1, 24, 48, 72 and 168 h (Figure 5). It was clearly observed an increase of the contrast 
after 1 h in liver and bladder, with ΔHounsfield units of 5.5 ± 1.5 and 5.2 ± 0.7 
respectively. In addition, postmortem quantification of silver by ICP-MS in different 
organs at one hour after injection confirmed the accumulation of PEGylated NPs 
preferentially in liver and spleen (Figure SX). The concentration of NPs in the liver was 
maximal at 24 h, with ΔHounsfield units of 9.1 ± 0.5, and were totally excreted, i.e. 
contrast returned to basal values, at 168 h. The presence of metal NPs in the bladder, 
which is governed by a glomerular filtration limit of 6-8 nm, could be explained by 
shrinkage or partial degradation of the organic coating on the NPs as already described 
by our group (ref.). In fact, the bladder showed maximal contrast at 24 h (ΔHounsfield 
units of 15.7 ± 1.5), which support the idea of a slow filtration rate following a 
degradation process. Thus, to demonstrate the partial excretion of NPs through the 
kidneys, urine was collected during the first 24 h after the intravenous injection of the 
PEGylated NPs. The collected urine was purified through centrifugal filters and analyzed 
by TEM, EDX and UV-Vis (Figure 6). TEM and EDX analysis showed the presence of 
the ternary NPs in urine (Figure 6a). On the other hand, the UV-Vis spectrum revealed 
the presence of the absorption band characteristic of the inorganic sample (Figure 6b). 
As for the kidneys, no accumulation was observed at any time, as expected for these NPs, 
since their hydrodynamic (HD) diameters are in the range of 25.4 ± 0.7 nm in plasma, 
which, as previously reported (ref.), falls below the size for effective retention in the 
corpuscles of the kidney cortex. Moreover, to determine the lifetime of the circulating 
PEGylated NPs in the bloodstream, samples of blood plasma were analyzed at 1 and 24 
h by TEM, EDX, UV-Vis and CT (Figure 7). The ex vivo analysis of plasma by CT 
showed an increase of contrast of 3.7 and 0.3 in Hounsfield units at 1 and 24 h, 
respectively (Figure 7a). The UV-Vis spectrum of the plasma showed the presence of the 
absorption band of the inorganic NPs (Figure 7b), and the TEM and EDX analyses 
confirmed the presence of the rare ternary NPs in plasma at both experimental times 
(Figure 7c and 7d). Thus, NPs showed high concentration in the bloodstream at one hour 
after injection and were still present at 24 h, although at very low concentration, indicating 
that NPs are being efficiently cleared out from the bloodstream at this time point, which 
is in good agreement with high concentrations found in liver and bladder. Finally, 
histology was performed on liver, kidneys and spleen (Supplementary Fig. XX) 
resulting no significant alterations in the tissues exposed to PEGylated metal NPs. These 
results confirm the long blood circulating times of the PEGylated rare ternary NPs, with 
partial renal clearance through urine and slow uptake by the mononuclear phagocyte 
system.  
CONCLUSIONS 
In summary, a novel X-ray computed tomography contrast agent based on a noble metal 
ternary chalcogenide Ag3AuSe2 was synthesized. The ternary Ag-Au-Se nanoparticles 
were transferred in water by a facile and fast ligand exchange method. The ligand 
molecule presents a dihydrolipoic acid as anchor group that binds strongly to the 
nanoparticle surface and a 3 kDa polyethylene glycol chain that allows the stabilization 
of the metal NPs in aqueous media giving excellent bioavailability and stealth properties. 
The functionalization of the ~8 nm inorganic core with the PEGylated dithiol DHLA-
PEGn-OH ligand resulted a high stable mono-dispersed ternary NPs with a HD diameter 
of 25 nm in blood plasma. The PEGylated ternary NPs exhibited good contrast in 
computed tomography with low toxicity effects, and long blood circulation times with 
minimal mononuclear phagocyte system retention. This behavior is ideal for most clinical 
applications and it has great potential for in vivo molecular imaging. 
EXPERIMENTAL SECTION 
Chemicals 
Reagents were obtained from commercial suppliers (Sigma Aldrich, Acros Organics, 
Fisher Scientific, Strem Chemicals and Rapp polymere) were used without further 
purification. Silver chloride (AgCl, 99.9%), selenium powder (Se, 99.99%), and tri-n-
octylphosphine (TOP, 97%) were obtained from Strem Chemicals. Lipoic acid, Poly 
ethylene glycol 3000 Da, Triethylamine, Gold (III) chloride trihydrate (HAuCl4·3H2O, 
≥99.9%), tetraoctylammonium bromide (TOAB, 98%), tri-n-octylphosphine oxide 
(TOPO, 99%), Oleylamine (OLAm, 70%) were purchased from Sigma-Aldrich. 
As solvents, Milli-Q water (18.2 MΩ, filtered with a filter pore size of 0.22 μM) from 
Millipore, toluene, isopropanol, ethanol, acetone, hexane, and anhydrous tetrahydrofuran 
were used (HPLC grade, Acros Organics). Purification of the water-soluble nanoparticles 
from free reagents was performed on centrifuge filters PALL with a molecular cut-off of 
100 kDa (4000 rpm 20 min). 
Methods 
TEM images were obtained on a FEI Tecnai G2 Twin microscope operated at an 
accelerating voltage of 100 kV. TEM samples were prepared by dropping a solution of 
the corresponding metal nanoparticles at ~1 g/L of metal concentration on a carbon-
coated copper grid and letting the solvent evaporate. The diameters were calculated on an 
average of hundred nanoparticles measured. The size distribution and zeta potential 
measurements of the dihydrolipoic acid derived metal nanoparticles were performed on 
a Zetasizer Nano ZS90 (Malvern, USA). The nanoparticles were dispersed in milli-Q 
water at a concentration of 50 mg/L of metal. The nanoparticles diameters were also 
measured in blood plasma by processing the animal blood after 1 hour of metal 
nanoparticles injection. The measurements were done on a cell type: ZEN0118-low 
volume disposable sizing cuvette, setting 3.068 as refractive index with 173º Backscatter 
(NIBS default) as angle of detection. The measurement duration was set as automatic and 
three as the number of measurements. As analysis model general purpose (normal 
resolution) was chosen. Spectroscopy measurements in the range of visible radiation 
(800-400) and the near ultraviolet (400-300 nm) were obtained on a Cary 100 UV-Vis 
spectrophotometer (Agilent Technologies) with a light path of 1 cm. FTIR spectra were 
recorded with a FTIR-4100 Jasco using a single reflection ATR accessory (MIRacle 
ATR, PIKE Technologies) coupled to a liquid nitrogen cooled mercury cadmium telluride 
(MCT) detector. All spectra were recorded in the 4000 to 800 cm-1 range at 4 cm-1 
resolution and accumulating 50 scans. Dihydrolipoic acid derived ligands were deposit 
as solid product and metal nanoparticles were prepared by dropcasting of a high 
concentrated nanoparticle solution onto a microscope slide (Thermo Scientific). The 1H 
NMR spectra were recorded on a NMR Bruker Ascend™ 400 MHz spectrometer. The 
spectra were measured either in CDCl3 or D2O. Ag and Au concentrations were 
determined on an ICP-HRMS (ICP-HRMS, Element XR, Thermo Fisher). The metal 
nanoparticles were digested with aqua regia (a mixture of three parts of HNO3 and one 
part of HCl). Briefly, to 25 µL of a solution of nanoparticles were added 2.5 mL of aqua 
regia in a volumetric flask. The mixture was left overnight. Then, milli-Q water was added 
to complete the total volume of 25 mL. Thermogravimetric analysis (TGA) was carried 
out by using a METTLER TOLEDO model TGA/DSC 1 in the temperature range of 30-
800 °C at a heating rate of 10 °C min−1 under a N2 flow (50 mL min
−1).  
Synthesis of Rare Ternary Ag-Au-Se Nanostructures. 
The formation of ternary  NPs takes place by the reaction of the pre-synthesized Ag2Se 
binary NPs with a Au(III) stock solution, as previously reported by some of us. (ref. 
Dalmases, M. et al. Chem. Mater. 2016, 28, 7017-7028)  
The synthesis of the Ag2Se precursor NPs was adapted from that published by Sahu and 
co-workers. (ref. Sahu, A.; Khare, A.; Deng, D. D.; Norris, D. J. Quantum Confinement 
in Silver Selenide Semiconductor Nanocrystals. Chem. Commun. 2012, 48, 5458−5460.) 
Briefly, 7.8 g TOPO and 6.6 mL oleylamine were degassed under vacuum at 120º C for 
30 minutes. Meanwhile, two precursor solutions were prepared in the glovebox: 474 mg 
(6 mmol) Se were dissolved in 6 mL TOP and 572 mg (4 mmol) AgCl were dissolved in 
4 mL TOP. Under N2 atmosphere, the temperature was raised to 180º C and the TOP/Se 
solution was injected. Once the temperature was recovered the AgCl-TOP precursor 
solution was injected. After 20 minutes of reaction, the heating was stopped and the 
solution was let cool naturally. Once at 50º C, 5 mL of BuOH was added to the reaction 
flask to avoid solidification of the solvent. Finally, the solution was washed three times 
with EtOH, centrifuging 4 minutes at 4500 rpm and re-dispersing with 4 mL toluene. In 
this point, the Ag2Se NPs were used as precursor to synthesize Ag3AuSe2 ternary 
nanoparticles, following our previously published protocol. (ref. Dalmases, M. et al. 
Chem. Mater. 2016, 28, 7017-7028) A gold ion solution in toluene was prepared via phase 
transfer of Au(III) ions from water to toluene, by using TOAB as a phase transfer agent. 
At this point, 180 μL of Ag2Se NPs solution (3.6 μM) were mixed with 2 mL of a 6 mM 
Au(III)-TOAB stock solution in toluene and shaken for 1 h. Then, the final solution was 
washed once with EtOH and the NPs re-dispersed in toluene. 
Synthesis of Di-Hydro Lipoic acid-PEGn-OH. 
 
LA-PEGn-OH was prepared using a modified literature procedure. In brief, poly ethylene 
glycol (Mw: 3000 g/mol, 1 mmol, 3.0 g), (±)-α-lipoic acid (0.206 g, 1 mmol), and DMAP 
(0.012 g, 0.1 mmol) were dissolved in 100 mL of tetrahydrofuran and 10 mL of 
dichloromethane in a round-bottom flask at 0ºC under nitrogen atmosphere. Afterwards, 
a solution of dicyclohexyl carbodiimide (Mw: 206 g/mol, 5 mmol, 1 g) was added 
dropwise. The mixture was stirred at 0ºC for one hour and then left at room temperature 
overnight. The reaction mixture was filtered through a filter paper and solvents were rota-
evaporated. The resulting oil was dissolved in 200 mL of chloroform and washed three 
times with HCl 1M (50 mL), NaHCO3 concentrated (50 mL) and brine (50 mL), dried 
over MgSO4, and filtered. After removing the volatiles under vacuum, flash 
chromatography on silica gel with CH2Cl2/MeOH (20:1) yielded 1.8 g (56%). Finally, to 
open the disulfide bond, LA-PEGn-OH (1.8 g, 0.56 mmol) in 10 mL of ethanol was added 
dropwise at 0ºC a solution of NaBH4 (85 mg, 2.25 mmol) in 5 mL of H2O. The mixture 
was stirred for 3 h at room temperature and the solvents were evaporated. The crude was 
dissolved in brine and the DHLA-PEGn-OH was extracted with CHCl2, dried over 
MgSO4, filtered and the volatiles evaporated under vacuum yielding the desired product 
quantitatively. 1H NMR spectroscopy confirmed the desired product DHLA-PEGn-OH. 
1H NMR was in agreement with the reported data. 1H NMR (400 MHz, CDCl3): δ (ppm) 
4.21-4.19 (m, 2H), 3.82-3.79 (m, 2H), 3.7-3.55 (m), 3.46-3.44 (m, 2H), 3.19-3.09 (m, 
2H), 2.46-2.40 (m, 1H), 2.37 (t, J = 7.2 Hz, 2H), 1.96-1.88 (m, 1H), 1.83 (br s, 1H), 1.75-
1.66 (m, 2H), 1.62-1.52 (m, 4H),1.42-1.34 (m, 2H), 1.29-1.21 (m, 2H), 1.10 (t, J = 7.1 
Hz, 2H). FTIR peaks (cm−1): 1466 (C-H bend vibration), 1359 (C-H bend vibration), 1341 
(C-H bend vibration), 1307 (anti-symmetric stretch vibration), 1268 (C-O stretch 
vibration), 1238 (C-O stretch vibration), 1092 (C-O-C stretch vibration), 942 (CH out-of-
plane bending vibration). 
Functionalization of metal nanoparticles (NPs) 
The functionalization of the metal NPs were performed following the protocol previously 
published (ref.). Briefly, in a separating funnel was added a solution of 1.0 mL of ternary 
nanoparticles (10 g/L of metal), 1.0 mL of the corresponding dyhydrolipoic acid-PEGn-
OH in a concentration of 0.1 M in CHCl3 and 50 µL of triethylamine. The mixture was 
shaken gently and diluted with 5 mL of toluene, 5 mL of milli-Q water and 10 mL of 
acetone. Then, the ternary nanoparticles were transferred into the aqueous phase. After 
that, the aqueous phase was collected in a round-bottom flask and the residual organic 
solvents were rota-evaporated. Then, the dyhydrolipoic acid derived ternary NPs were 
purified in centrifuge filters with a molecular weight cut-off of 30 kDa, at 4500 rpm for 
20 min. In each centrifugation, the functionalized ternary NPs were re-suspended with 
milli-Q water. The purification step was repeated several times until the filtered solution 
was clear. Then, the dyhydrolipoic acid derived ternary NPs were re-suspended in PBS 
buffer. Finally, to ensure high stable mono-dispersed ternary nanoparticles, the solution 
was centrifuged at 1500 rpm for 5 min.  
Cytotoxicity assays. 
C6 rat glioma cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) 
supplemented with 2 mM L-glutamine, 10% fetal bovine serum (FBS) and 1% 
penicillin/streptomycin at 37º C in an incubator with a humidified atmosphere containing 
5% CO2. In order to perform the cytotoxicity assays, the C6 cells were plated at a density 
of 1 x 104 cells/well in a 96-well plate at 37ºC in 5% CO2 atmosphere (200 µL per well, 
number of repetitions = 5). After 24 h of culture, the medium in the wells was replaced 
with fresh medium containing the PEGylated ternary NPs in varying concentrations from 
0.5 µg/mL to 500 µg/mL. After 24 h, the medium was removed, and 200 µL of fresh 
medium with MTT (0.5 mg/mL) was added to each well. After 2 h of incubation at 37ºC 
and 5% CO2 the medium was removed and the formazan crystals were solubilized with 
200 µL of DMSO, and the solution was vigorously mixed to dissolve the reacted dye. The 
absorbance of each well was read on a microplate reader (Dynatech MR7000 instruments) 
at 550 nm. The relative cell viability (%) and its error related to control wells containing 
cell culture medium without nanoparticles were calculated by the equations: 











where σ is the standard deviation. 
In vitro and in vivo X-ray. 
In vivo mice experiments were performed in accordance with the ethical guidelines of 
Andalusian government. Male Balb/c mice (n = 3) with ca. 22 g in weight, provided by 
Janvier Labs were used. Animals were anesthetized with 1% isoflurane, the tail vein was 
cannulated and then the animals were placed in the X-Ray scanner. The functionalized 
nanoparticles were administered intravenously via tail vein at a concentration of 10 mg 
nanoparticles per kg. 
The 2-D X-Ray images were acquired in a Bruker in vivo Xtreme multimodal imaging 
system with back-illuminated 4 mega-pixel camera (pixel dimensions 35 × 35 μm). The 
adquisition time was 1.2 seconds, the F-stop (aperture) was 1.4 and the X-ray energy was 
45 kVp.  
The CT images were acquired in a Bruker Albira small animal CT system. The X-ray 
Focal Spot Size (Nominal) used was 35 μm and the Energy used was 45 kVp, working at 
400 µA. Values are Hounsfield units with the adjusted scale to see differences between 
soft tissues (leaving the bones overexposed) in 1000 images.  
Histological analysis of the major organs 
After one week post injection of the ternary NPs, the mice were sacrificed and the major 
organs were extracted. Histology of the major organs was determined by light 
microscopy. The tissues were fixed in 4% Formaldehyde (Panreac, pH 7 buffered) for 48 
h, changing the 4% Formaldehyde after 24 h. Then, the samples were dehydrated through 
graded ethanol, and embedded in paraffin (temperature 56ºC for 2 h under stirring and 
vacuum). At this point, the Haematoxylin and Eosin stain was performed: Haematoxylin 
and Eosin (H&E): The paraffin-embedded samples were sectioned at 7 μm thickness and 
then were deparaffinized, rehydrated and stained with H&E, then dehydrated in ascending 
concentrations of ethanol, cleared in xylene and mounted in commercial glass slides. 
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Figure 1. PEGylation of ternary Ag-Au-Se nanoparticles. (A) Scheme of the 
functionalization of lipoic acid-PEGn-OH nanoparticles. Representative TEM image of 
the NPs before (B) and after (C) functionalization with dyhydrolipoic acid-PEGn-OH. 
Scale bar corresponds to 50 nm. Insets correspond to histograms of the TEM diameters 




Figure 2. Histogram of DLS sizes in PBS (left) and plama (right). Table of average 
hydrodynamic diameters, zeta potential of DHLA-PEGn-OH nanoparticles.  
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PBS 30.6  9.4 0.28 -7.6
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Figure 3. Characterization of PEGylated ternary Ag-Au-Se nanoparticles. (A) FTIR 
spectra of as-prepared ternary Ag-Au-Se NPs (a) and NP-DHLA-PEGn-OH (b) and 
ligand DHLA-PEGn-OH (c). (B) 1H NMR spectra of ligand DHLA-PEGn-OH (blue) and 
NP-DHLA-PEGn-OH. (C) UV-vis spectra of the NP-DHLA-PEGn-OH showing a 
plasmonic abpsortion in the range between 500-700 nm (black) and NPs before ligand 
exchange process (grey). Images of the as-prepared ternary Ag-Au-Se NPs (left) and 
PEGylated Ag-Au-Se nanoparticles (right) functionalization. (D) Thermo-gravimetric 











































































Figure 4. Cytotoxicity effects of PEGylated ternary Ag-Au-Se nanoparticles by the MTT 
assay of C6 cells treated for 24 h (A) at different concentrations. (B) Plot of cell death 




Figure 5. Representative in vivo X-rays CT images at different experimental times after 
the intravenous injection of PEGylated ternary Ag-Au-Se nanoparticles. X-rays CT 
images of liver (Top) and bladder (Bottom) at 0, 1, 24, 72 and 168 h after nanoparticles 
injection. Values are Hounsfield units with the adjusted scale to see differences between 
soft tissues (leaving the bones overexposed). Table. Δ Hounsfield units values of liver 
and bladder at different times after intravenously injection of NPs. The average values 














































































0 h 1 h 72 h 168 h
Time 0 h 1 h 24 h 72 h 168 h
Δ HU Liver 0  1.9 5.5  1.5 9.1  0.5 4.6  1.0 - 1.5  0.9
Bladder 0  1.6 5.2  0.7 15.7  1.5 7.8  0.2 1.8  0.7
 
 
Figure 6. Analysis of excreted ternary Ag-Au-Se nanoparticles through the urine at 24 h 
after their intravenous injection. (A) Representative TEM image of NPs after purification 
and concentration by centrifugal PALL filter (MWCO: 30 kDa). Scale bar corresponds to 
50 nm. (EDX spectrum of excreted 6 nm NPs). (B). UV-vis spectrum of the urine 





Figure 7. Analysis of blood plasma. (A) X-ray CT images of plasma at different 
experimental times (0, 1 and 24 h) after intravenously injection of ternary Ag-Au-Se 
nanoparticles and a solution of NPs before injection. Average values were obtained by 
performing three experiments. (B) UV-vis spectra of blood plasma at 0, 1 and 24 h after 
intravenously injection of NPs. Representative TEM image of extracted blood plasma at 
1 h (C) and 24 h (D) after injection of NPs. Scale bars correspond to 50 nm.  
 
 
